Park Medi World IPO: Check IPO Date, Live Subscription and Key Details
Park Medi World Limited, established in 2011, is the second largest private hospital chain in North India and the largest in Haryana, operating 14 NABH and NABL accredited multi-super speciality hospitals under the 'Park' brand. With a total bed capacity of 3,250 as of September 30, 2025, the company offers over 30 specialities, including oncology, orthopaedics, and critical care. The business employs a cluster-based expansion strategy and has a strong track record of successfully acquiring and integrating hospitals, contributing significantly to its revenue and profitability.
Price Range
₹154.0 - ₹162.0
Issue Size
₹920 Cr
Lot Size
92 shares
IPO Type
Mainboard
GMP
₹5(+3.09%)
Est. Listing Price
₹167
Estimate Profit
₹460
Retail Portion
35%
Key Metrics
Check Live GMPGMPFace Value
₹2
EPS
6.44
P/E Ratio
25.14
RoNW
20.08%
ROE
20.68%
Debt to Equity
0.61
Advertisement
Timeline
IPO Opens
10 Dec
IPO Closes
12 Dec
Allotment
15 Dec
Listing
17 Dec
IPO Timeline & Listing Details
| Event | Date | Details |
|---|---|---|
| IPO Open Date | 10 December 2025 | Subscription starts |
| IPO Close Date | 12 December 2025 | Subscription ends |
| Allotment Date | 15 December 2025 | Allotment |
| Listing Date | 17 December 2025 | Listing |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Retail (Min) | 1 | ₹14,904 |
Retail (Max)Just less than ₹2,00,000 | 13 | ₹1,93,752 |
SHNI (Min)Just above ₹2,00,000 | 14 | ₹2,08,656 |
SHNI (Max)Below ₹10,00,000 | 67 | ₹9,98,568 |
BHNIAbove ₹10,00,000 | 68 | ₹10,13,472 |
IPO Reservation Details
| Category | Reservation |
|---|---|
| QIB (Qualified Institutional Buyer) | 50% |
| NII (Non-Institutional Investor) | 15% |
| Retail | 35% |
| Total | 100.00% |
IPO Objectives
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries (₹380.00 Cr).
- Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively (₹60.50 Cr).
- Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri (₹27.46 Cr).
- Unidentified inorganic acquisitions and general corporate purposes.
Strengths
- The company holds Regional Dominance, being the second largest private hospital chain in North India and the largest in Haryana, which provides a strong regional base and cluster-based efficiency.
- It has a Proven Growth Model with a strong track record of successfully acquiring and integrating hospitals, which contributed over 55% of revenue/profit in H1 FY26.
- The business delivers High-Quality, Affordable Care, with all hospitals being NABH accredited and a model focused on the massive middle-class segment.
- The Strategic Use of Funds is highlighted by the largest objective being debt repayment (₹380 Cr), which significantly deleverages the balance sheet and is expected to boost future margins.
- It maintains Robust Financials, showing consistent growth in Net Worth, a high PAT Margin of 15.30% (FY25), and a strong EBITDA Margin of 26.71%.
Weaknesses
- There is Geographic Concentration with a heavy dependence on Haryana for revenue (over 74%), increasing vulnerability to regional regulatory or economic changes.
- The Aggressive Valuation with a Post-IPO P/E of 25.14x is considered fully priced and requires sustained high growth in the coming years.
- The company faces Intense Competition in the North Indian market against large established players like Medanta and Fortis Healthcare.
- It carries Inorganic Growth Risk due to a high reliance on acquiring and successfully integrating distressed assets, which carries inherent operational and financial risks.
- The high Contingent Liabilities and corporate guarantees (constituting 71.58% of Net Worth as of Sep 30, 2025) pose potential future financial strain.
Advertisement
Financial Performance
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets (₹ Cr.) | 2,320.93 | 2,133.7 | 1,912.1 | 1,592.82 |
| Revenue (₹ Cr.) | 823.39 | 1,425.97 | 1,263.08 | 1,272.18 |
| PAT (₹ Cr.) | 139.14 | 213.22 | 152.01 | 228.19 |
| Net Worth (₹ Cr.) | 1,153.05 | 1,021.86 | 815.98 | 667.55 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Park Medi World | 6.09 | 25.14 | 20.68% | 1,153.05 |
| Apollo Hospitals | 11.38 | 59.79 | 18.39% | 8,653 |
| Fortis Healthcare | 7.11 | 64.57 | 10.75% | 9,169 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0.28x | 0.34x | 12.07x |
| NII | 0.7x | 1.46x | 15.93x |
| S-HNI | 0.96x | 1.87x | 11.12x |
| B-HNI | 0.57x | 1.26x | 18.34x |
| RII | 0.67x | 1.27x | 3.32x |
| Total | 0.56x | 1.05x | 8.52x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 1,13,58,026 | 13,71,09,808 | 2,221.18 |
| NII | 85,18,519 | 13,57,18,492 | 2,198.64 |
| Small NII | 28,39,507 | 3,15,62,900 | 511.32 |
| Big NII | 56,79,012 | 10,41,55,592 | 1,687.32 |
| RII | 1,98,76,543 | 6,60,00,616 | 1,069.21 |
| Total | 3,97,53,088 | 33,88,28,916 | 5,489.03 |
Advertisement
Company Details
- Park Medi World Ltd.
- 12, Meera Enclave Near Keshopur, Bus Depot, Outer Ring Road, New Delhi, New Delhi-110018
- + 91 124 696 000
- company.secretary@parkhospital.in
- http://www.parkhospital.in/
Registrar Details
- Kfin Technologies Ltd.
- 04067162222, 04079611000
- parkmedi.ipo@kfintech.com
- https://ipostatus.kfintech.com/
Frequently Asked Questions
What is the key strength of Park Medi World in North India?
Park Medi World is the second largest private hospital chain in North India and the largest private hospital chain in Haryana (with 1,600 beds), operating a network of 14 NABH-accredited multi-super speciality hospitals.
When will the Park Medi World IPO open and close for subscription?
The Park Medi World IPO will open on December 10, 2025, and close on December 12, 2025.
What is the primary use of the Fresh Issue proceeds?
The largest portion of the Fresh Issue funds (₹380.00 Cr) is dedicated to repayment/prepayment of outstanding borrowings, significantly strengthening the balance sheet and improving future profitability.
What is the IPO price band and tentative listing date?
The price band is ₹154.00 to ₹162.00 per share, and the tentative listing date on the BSE and NSE is December 17, 2025.
What is the valuation of the Park Medi World IPO based on recent performance?
The IPO is priced at a P/E ratio of 25.14x based on the annualized H1 FY26 PAT, which is considered aggressive by market experts.
What accreditations do Park Hospitals hold?
All 14 multi-super specialty hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also accredited by NABL.
Loading comments...